ZTE
-
Chinese Smartphone Companies Are Gaining A Foothold In The US
Jul 7, 2016(Comments: 0)July 7, 2016 (IP Flow) — Until recently, only Huawei and ZTE were internationally recognized Chinese IT companies. Nowadays, however, Chinese businesses in this field are growing by leaps and bounds. Qualcomm recently filed patent infringement complaints against Meizu... -
Vringo Settles…Now What?
Dec 15, 2015(Comments: 0)Dec. 15, 2015 (Mimesis Law) — Gaston dissects the deal that put Vringo and ZTE’s long-running IP battle to bed....Read More -
IP Flow Links – Settlement Reached In “Happy Birthday” Copyright Case
Dec 11, 2015(Comments: 0)Dec. 11, 2015 (Mimesis Law) — Hi folks, your weekly IP news update: A settlement was reached in the copyright case over “Happy Birthday”. Warner/Chappell Inc were due to go on trial next week to decide whether... -
Court Rules that ZTE Must Bring Its GC to Deposition in US, Despite Arrest Fears
Aug 12, 2015(Comments: 0)Aug. 12, 2015 (Mimesis Law) — Back in late July, we discussed Judge Kaplan’s Order compelling ZTE to produce its general counsel, Guo Xiaoming, for deposition in the United States, to answer questions about his role in purportedly... -
SDNY Judge Smacks Down ZTE, VRNG Draws Blood
Jul 27, 2015(Comments: 1)July 27, 2015 (Mimesis Law) — Judge Kaplan pulled no punches in rejecting ZTE’s attempts to shield its general counsel from an immediate deposition in the breach of confidentiality case filed by Vringo in the Southern District... -
Vringo & ZTE Square Off in SDNY, China’s Pressure Tactics “Exposed”
Jul 23, 2015(Comments: 1)July 23, 2015 (Mimesis Law) — Vringo (VRNG) investors have been a beaten bunch since the devastating invalidation of Vringo’s trial-winning patents from the company’s long running saga with Google. While the fate of that case... -
The Markman Note: Bass Keeps Fishing for Pharma Shorts
Apr 27, 2015(Comments: 2)Apr. 28, 2015 (Mimesis Law) — It was another busy week at the intersection of investing and intellectual property, particularly in the bio-pharma sector. Welcome to the fifth issue of the Markman Note, where we take...